Status:
RECRUITING
Transdiagnostic Cognitive Biomarkers
Lead Sponsor:
University of Minnesota
Conditions:
Pain
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall objective of this study is to determine the feasibility of identifying transdiagnostic biomarkers of cognitive function mediated by neuromodulation of the dorsolateral prefrontal cortex th...
Detailed Description
This study aims to test the feasibility of procedures aimed at discovering transdiagnostic biomarkers for cognitive impairment in chronic pain and depression. Fifteen healthy control participants and ...
Eligibility Criteria
Inclusion
- Arm 1, healthy controls:
- Have access to the online study platform.
Exclusion
- under 18, non-English speaking
- Arm 2: pain and depression:
- Inclusion Criteria:
- Pain or depression
Key Trial Info
Start Date :
April 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04864080
Start Date
April 11 2022
End Date
March 1 2027
Last Update
February 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Minnesota
Minneapolis, Minnesota, United States, 55455